Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06112236
NCT06112236
Active, not recruiting
Not Applicable

Effects of Treatments for Anemia and Iron Deficiency on the Electrolyte Balance in Lung Transplant Recipients: A Special Focus on Hypophosphatemia

University of Zurich1 site in 1 country250 target enrollmentStarted: February 17, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHypophosphatemia

Overview

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
250
Locations
1
Primary Endpoint
Change of serum phosphate level
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

The aim of this study is to generate evidence regarding hypophosphatemia after iron infusion in lung transplant recipients in context of anemia and/or iron deficiency.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •lung transplant recipient
  • •treated at the University Hospital Zurich between 2015 until 2022

Exclusion Criteria

  • •Denied general consent

Outcomes

Primary Outcomes

Change of serum phosphate level

Time Frame: Baseline and up to 90 days after iron infusion

Change of serum phosphate level before and after iron infusion

Secondary Outcomes

  • Change of urin phosphate level(Baseline and up to 90 days after iron infusion)
  • Change of serum albumin(Baseline and up to 90 days after iron infusion)
  • Change of serum and urin calcium(Baseline and up to 90 days after iron infusion)
  • Complications after iron infusion(2015-2022)
  • Therapeutic management(2015 to 2022)
  • Change of serum magnesium(Baseline and up to 90 days after iron infusion)
  • Change of mean corpuscular volume (MCV)(Baseline and up to 90 days after iron infusion)
  • Change of mean corpuscular hemoglobin (MCH)(Baseline and up to 90 days after iron infusion)
  • Change of hemoglobin(Baseline and up to 90 days after iron infusion)
  • Predictors(baseline and up to 90 days after iron infusion)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron SupplementPrevention of Anemia
NCT02957643Hippocration General Hospital50
Recruiting
Not Applicable
Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 MonthsIron-Deficiency AnemiaNeurobehavioral ManifestationsGrowth DisordersNutritional Status
NCT06662045Pingshan District Maternal & Child Healthcare Hospital of Shenzhen1,000
Completed
Not Applicable
Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.Autosomal Dominant Hypophosphatemic Rickets
NCT02233322Indiana University8
Completed
Phase 3
Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve ReplacementAnemiaAortic Stenosis
NCT02390102Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec117
Unknown
Phase 4
Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver TransplantationLiver TransplantationBlood Loss
NCT04475887Medical University of Vienna60